These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 23267883)

  • 1. [Analysis of indoleamine 2, 3-dioxygenase expression in breast cancer patients with bone metastasis].
    Sakurai K; Fujisaki S; Nagashima S; Maeda T; Shibata M; Gonda K; Tomita R; Suzuki S; Hara Y; Enomoto K; Amano S
    Gan To Kagaku Ryoho; 2012 Nov; 39(12):1776-8. PubMed ID: 23267883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Indoleamine 2,3-dioxygenase activity in breast cancer patients with local recurrence or distant metastases].
    Sakurai K; Fujisaki S; Suzuki S; Nagashima S; Maeda T; Tomita R; Hara Y; Hirano T; Enomoto K; Amano S
    Gan To Kagaku Ryoho; 2014 Oct; 41(10):1304-6. PubMed ID: 25335725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Indoleamine 2,3-dioxygenase activity during chemotherapy in patients with breast cancer].
    Sakurai K; Matsuo S; Enomoto K; Tani M; Kitajima A; Amano S
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):1991-3. PubMed ID: 20037301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study of indoleamine 2,3-dioxygenase expression in patients with breast cancer].
    Sakurai K; Amano S; Enomoto K; Kashio M; Saito Y; Sakamoto A; Matsuo S; Suzuki M; Kitajima A; Hirano T; Negishi N
    Gan To Kagaku Ryoho; 2005 Oct; 32(11):1546-9. PubMed ID: 16315864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Indoleamine 2,3-dioxygenase activity during toremifene therapy for aromatase inhibitor-resistant metastatic breast cancer].
    Sakurai K; Fujisaki S; Nagashima S; Maeda T; Tomita R; Suzuki S; Hara Y; Hirano T; Enomoto K; Amano S
    Gan To Kagaku Ryoho; 2014 Oct; 41(10):1286-8. PubMed ID: 25335719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Indoleamine 2, 3-dioxygenase activity during neoadjuvant chemotherapy in patients with breast cancer].
    Sakurai K; Fujisaki S; Nagashima S; Maeda T; Tomita R; Suzuki S; Hara Y; Hirano T; Enomoto K; Amano S
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):1578-80. PubMed ID: 24393854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased serum kynurenine/tryptophan ratio correlates with disease progression in lung cancer.
    Suzuki Y; Suda T; Furuhashi K; Suzuki M; Fujie M; Hahimoto D; Nakamura Y; Inui N; Nakamura H; Chida K
    Lung Cancer; 2010 Mar; 67(3):361-5. PubMed ID: 19487045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Indoleamine 2, 3-dioxygenase activity for breast cancer patients with recurrence 5 or more years after surgery].
    Sakurai K; Fujisaki S; Nagashima S; Maeda T; Tomita R; Suzuki S; Hara Y; Enomoto K; Amano S
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):1590-2. PubMed ID: 24393858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Indoleamine 2,3-dioxygenase expression in breast cancer patients during chemotherapy].
    Sakurai K; Enomoto K; Kitajima A; Tani M; Amano S; Shiono M
    Gan To Kagaku Ryoho; 2008 Nov; 35(12):2265-7. PubMed ID: 19106591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Indoleamine 2,3-Dioxygenase Activity during Fulvestrant Therapy for Multiple Metastatic Breast Cancer Patients].
    Sakurai K; Fujisaki S; Adachi K; Suzuki S; Masuo Y; Nagashima S; Hara Y; Hirano T; Enomoto K; Tomita R; Gonda K
    Gan To Kagaku Ryoho; 2016 Oct; 43(10):1233-1236. PubMed ID: 27760945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Indoleamine 2,3-Dioxygenase Activity during Fulvestrant Therapy for Aromatase Inhibitor-Resistant Metastatic Breast Cancer].
    Sakurai K; Fujisaki S; Suzuki S; Adachi K; Nagashima S; Masuo Y; Tomita R; Gonda K; Enomoto K; Amano S; Matsuo S; Umeda N
    Gan To Kagaku Ryoho; 2015 Oct; 42(10):1225-7. PubMed ID: 26489554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Indoleamine 2, 3-dioxygenase activity during chemotherapy or trastuzumab therapy in patients with breast cancer].
    Sakurai K; Fujisaki S; Nagashima S; Maeda T; Shibata M; Gonda K; Tomita R; Suzuki S; Hara Y; Enomoto K; Amano S
    Gan To Kagaku Ryoho; 2012 Nov; 39(12):1791-3. PubMed ID: 23267888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Indoleamine 2,3-Dioxygenase Activity in Intracystic Breast Tumors].
    Sakurai K; Fujisaki S; Adachi K; Suzuki S; Masuo Y; Nagashima S; Hara Y; Enomoto K; Hirano T; Tomita R; Gonda K
    Gan To Kagaku Ryoho; 2016 Oct; 43(10):1295-1297. PubMed ID: 27760965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High activity of indoleamine 2,3 dioxygenase enzyme predicts disease severity and case fatality in bacteremic patients.
    Huttunen R; Syrjänen J; Aittoniemi J; Oja SS; Raitala A; Laine J; Pertovaara M; Vuento R; Huhtala H; Hurme M
    Shock; 2010 Feb; 33(2):149-54. PubMed ID: 19487973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Indoleamine 2,3-Dioxygenase Activity during I131-Radioisotope Therapy for Metastatic Thyroid Cancer].
    Sakurai K; Fujisaki S; Adachi K; Suzuki S; Masuo Y; Nagashima S; Hara Y; Tomita R; Gonda K; Hirano T; Enomoto K
    Gan To Kagaku Ryoho; 2015 Oct; 42(10):1259-61. PubMed ID: 26489565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms.
    Schefold JC; Zeden JP; Fotopoulou C; von Haehling S; Pschowski R; Hasper D; Volk HD; Schuett C; Reinke P
    Nephrol Dial Transplant; 2009 Jun; 24(6):1901-8. PubMed ID: 19155537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Indoleamine 2,3-dioxygenase activity during chemotherapy or hormone therapy in patients with breast cancer].
    Sakurai K; Enomoto K; Amano S
    Gan To Kagaku Ryoho; 2010 Nov; 37(12):2252-4. PubMed ID: 21224538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum activity of indoleamine 2,3-dioxygenase predicts prognosis of community-acquired pneumonia.
    Suzuki Y; Suda T; Yokomura K; Suzuki M; Fujie M; Furuhashi K; Hahimoto D; Enomto N; Fujisawa T; Nakamura Y; Inui N; Nakano Y; Nakamura H; Chida K
    J Infect; 2011 Sep; 63(3):215-22. PubMed ID: 21784100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High Indoleamine 2,3-Dioxygenase Is Correlated With Microvessel Density and Worse Prognosis in Breast Cancer.
    Wei L; Zhu S; Li M; Li F; Wei F; Liu J; Ren X
    Front Immunol; 2018; 9():724. PubMed ID: 29719533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between indoleamine 2,3-dioxygenase activity and lymphatic invasion propensity of colorectal carcinoma.
    Engin A; Gonul II; Engin AB; Karamercan A; Sepici Dincel A; Dursun A
    World J Gastroenterol; 2016 Apr; 22(13):3592-601. PubMed ID: 27053851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.